Jubilant Pharmova Ltd (JUBLPHARMA)

πŸ“Š End of Day Bhavcopy

Date: 2025-09-09

Price: 1110.30
% Change: 1.86% (Prev Close: 1090.00)

Volume: 1,26,775
% Change: -86.55% (Prev Volume: 9,42,391)

Delivery: 67,560
Delivery % : 53.29
% Change: -72.59% (Prev Delivery: 2,46,449)

Turnover: 1,400 Lacs
% Change: -86.67% (Prev Turnover: 10,502)

πŸ’Ή EOD Valuation

P/E Ratio: 38.43
P/B Ratio: 2.83
Market Cap: 17687 Rs. Cr.

Fundamental Data

Date: 05-09-2025

🏷️ Company Basics

Symbol: JUBLPHARMA
Market Cap: 16298 Rs. Cr.
Face Value: 1.00 Rs.

52 Week High: 1309.90
52 Week Low: 802.00

All-Time High: 1309.90 Rs.
All-Time Low: 57.95 Rs.

Stock Price Increase (% Return) %

% Return (1 mth |3 mth | 6 mth | 1 Yr | 3 Yrs | 5 Yrs):
-5.98% | -7.70% | 15.61% | 13.41% | 47.44%

πŸ‘₯ Shareholding Pattern

Promoter Holding

Promoter Holding: 47.68%

Change (3Y | 1Y): -3.00% | -3.00%

Pledged %: 0.00%

FII Holding

FII Holding: 17.40%

Change (3Y | 1Y): -6.07% | 0.17%

DII Holding

DII Holding: 9.52%

Change (3Y | 1Y): 8.90% | 2.47%

Public Holding: 24.83%

🏦 Financial Strength

Debt to Equity: 0.44
Debt: 2731.00 Rs. Cr.

Book Value: 392.65 Rs.
Current Ratio: 1.65
Interest Coverage: 4.08
Free Cash Flow: -38.50 Rs. Cr.

πŸ“ˆ Growth & Sales

Sales Growth: 8.12%

Sales Growth Qtr (YOY | QoQ):
9.76% | -1.46%

Sales Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
3.90% | 5.68% | 8.12%

πŸ’° Profit & Earnings

Profit Growth %

Profit Growth: 106.59%

Profit Growth Qtr (YOY | QoQ):
-3.72% | -32.25%

Profit Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
-9.56% | 10.27% | 106.59%

EPS Rs.

EPS (TTM): 28.89 Rs.

EPS Qtr (Last Year | Latest):
30.26 Rs. | 6.46 Rs.

EPS Annual (Last Annual | Annual March):
4.84 Rs. | 52.69 Rs.

EPS Growth Variation % (5 Yrs | 3 Yrs):
-9.56% | 10.27%

Net Profit Rs. Cr.

Net Profit (TTM): 457.00 Rs. Cr.

Net Profit (Annual - March): 836.30 Rs. Cr.

Net Profit Qtr (Last Year Q | Previous Q | Latest Q):
481.80| 151.30 | 102.50

EBITDA Rs. Cr.

EBITDA (Quarter): 301.50 Rs. Cr.
EBITDA (Previous Yr Ql): 265.50 Rs. Cr.

EBITDA (Annual - March): 1230.00 Rs. Cr.
EBITDA (Previous Annual): 993.60 Rs. Cr.

EBITDA (5 Yrs | 3 Yrs) %:
-7.39% | 1.94%

πŸ“Š Profitability Ratios

Operating Margin (OPM)

OPM (TTM): 16.36%

OPM Qtr (Previous | Current):
17.90% | 15.23%

OPM Annual (5 Yrs | Last Yr | March):
16.66% | 13.44% | 16.22%

Return on Equity %

ROE: 9.55%

ROE (5 Yrs | 3 Yrs | Last Yr):
5.62% | 1.41% | 0.84%

Return on Capital Employed %

ROCE: 9.54%

ROCE (5 Yrs | 3 Yrs | Last Yr):
8.23% | 6.47% | 6.74%

Return on Assets %

ROA (TTM): 4.64%

ROA (5 Yrs | 3 Yrs | Last Yr):
2.76% | 0.41% | 0.37%

PEG Ratio: 3.27
Dividend Yield: 0.49%

PE 3 Yrs: 58.36
PE 5 Yrs: 32.31

Dividend Yield: 0.49%

πŸ‘₯ Company

Jubilant Pharmova Ltd

JUBLPHARMA

Promoter Holding: %